Senti Biosciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +363.5% | +481.5% | +87.1% | -53.8% | -100.0% | – | |
| – | +9.9% | -81.1% | +30.2% | +33.8% | – | – | |
| – | – | +481.5% | +87.1% | -53.8% | – | – | |
| – | +9.9% | +37.6% | +55.2% | -5.6% | +6.9% | +9.4% | |
| – | +26.7% | +128.4% | +92.2% | -14.6% | -32.6% | +11.3% | |
| – | +239.4% | +70.3% | +75.3% | +26.4% | -35.5% | -1.5% | |
| – | – | – | – | – | – | – | |
| – | – | -87.5% | +35,536.4% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | -92.7% | -113,000.0% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.